ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Navigate Complex Ancillary Supply Sourcing Challenges

  Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain. 

• IMP Labeling: EU CTR Transition Considerations

  Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.

• Global Clinical Supply Solutions For Every Trial

  A reliable clinical supply chain strategy is as essential as a company’s discovery program. Seek a partner who can help guide a comprehensive  strategy and manage day-to-day activities.

• Managing Clinical Trial Supply Challenges In Complex Studies

  Complex studies require flexible supply strategies that can adjust to shifting timelines, varied modalities, and global site needs. Adaptive, scalable planning helps lower risk.

   

• Optimizing IRT For Clinical Supply Management

  Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.

• Creating Accurate, Efficient, And Effective CDMO Project Proposals

  To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.

• Advantages Of Robotic Aseptic Processing

  Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.

• Logistics In Cell Therapy: Reducing Workflow Risk

  Explore key steps that should be taken when executing a cell therapy clinical trial, from selecting the right sites to optimizing study retention.

• Key Considerations For Labeling Your Cell Or Gene Therapy

  As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.

• Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial

  Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.